Wellbutrin XR 300 mg tablete s prilagođenim oslobađanjem
| Name | Wellbutrin XR 300 mg tablete s prilagođenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-345088727 |
| Active Substance | bupropionklorid |
| Composition | jedna tableta sadrži 300 mg bupropionklorida |
| Pharmaceutical Form | tableta s prilagođenim oslobađanjem |
| Manufacturer | Aspen Bad Oldesloe GmbH, Bad Oldesloe, Njemačka Glaxo Wellcome S.A., Aranda de Duero, Burgos, Španjolska |
| Marketing Authorisation Holder | GlaxoSmithKline Trading Services Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Irska |
| Marketing Authorisation Date | 20.08.2021 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/372 |
| Registration Number | 381-12-01/70-21-22 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | N06AX12 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
